Summary: Medtronic’s recent earnings report has boosted investor confidence, suggesting the worst may be over
Summary: AbbVie is set to acquire ImmunoGen for $10.1 billion, gaining Elahere, a promising ovarian
Summary: 3M’s stock has faced significant pressure since 2020 following the Earplug Lawsuit, erasing all
Summary: Tech stock valuations are becoming less compelling, but not in bubble territory. Julian Lin
Summary: As a Dividend King with six decades of dividend growth to its credit and
Summary: AbbVie Inc. is set to acquire drug developer ImmunoGen, Inc. for $10.1 billion, diversifying
Summary: 3M has a string of decent quarterly earnings beats and stock price reactions. With
Summary: The weight loss drug, Zepbound, faces immense competition and may lose its battle once
Summary: Salesforce stock jumped around 10% after reporting solid, if unexceptional, results, suggesting we have
Summary: Amazon’s 2023 fundamental performance exceeded probably the most optimistic investor expectations. Although there could